Literature DB >> 15945015

Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration.

M Nicolò1, D Ghiglione, S Lai, G Calabria.   

Abstract

PURPOSE: To report two cases of occult choroidal neovascularization (CNV) and serous pigment epithelial detachment (PED) treated with intravitreal triamcinolone (IVT) injections.
METHODS: Interventional case reports.
RESULTS: Both patients showed an increase in visual acuity and a complete flattening of the PED at 10 months (Case 1) and 4 months (Case 2) after IVT injections. No complications or adverse effects are reported.
CONCLUSIONS: Future studies should be designed to investigate if IVT can effectively influence the clinical and functional outcome of eyes with serous PED and occult CNV secondary to age-related macular degeneration, for which at the moment no treatment has been shown to be effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945015

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

1.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Authors:  Matthias Bolz; Stephan Michels; Wolfgang Geitzenauer; Franz Prager; Ursula Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

3.  Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.

Authors:  Pallavi Tyagi; Zain Juma; Yong Keen Hor; Neil W Scott; Andreea Ionean; Cynthia Santiago
Journal:  BMC Ophthalmol       Date:  2018-06-22       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.